Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lucrezia Rosati"'
Autor:
María Jesús Rodríguez-Sojo, Antonio Jesús Ruiz-Malagón, Laura Hidalgo-García, Jose Alberto Molina-Tijeras, Patricia Diez-Echave, Laura López-Escanez, Lucrezia Rosati, Elena González-Lozano, Laura Cenis-Cifuentes, Jorge García-García, Federico García, Iñaki Robles-Vera, Miguel Romero, Juan Duarte, José Luis Cenis, Antonio Abel Lozano-Pérez, Julio Gálvez, María Elena Rodríguez-Cabezas, Alba Rodríguez-Nogales
Publikováno v:
Antioxidants, Vol 12, Iss 4, p 978 (2023)
Obesity is a global health issue, in which modifications in gut microbiota composition have a key role. Different therapeutic strategies are being developed in combination with diet and exercise, including the use of plant extracts, such as those obt
Externí odkaz:
https://doaj.org/article/aaf8405538e142b596fc6a58018cb6ed
Autor:
Costanza Spadini, Nicola Demitri, Marialaura Marchetti, Paola Storici, Barbara Campanini, Giannamaria Annunziato, Clotilde Silvia Cabassi, Mattia Iannarelli, Joana Magalhães, Andrea Mozzarelli, Sara Flisi, Nina Franko, Gabriele Costantino, Lucrezia Rosati, Stefano Bettati, Marco Pieroni
Publikováno v:
ACS Infectious Diseases 7 (2021): 281–292. doi:10.1021/acsinfecdis.0c00378
info:cnr-pdr/source/autori:Annunziato G.; Spadini C.; Franko N.; Storici P.; Demitri N.; Pieroni M.; Flisi S.; Rosati L.; Iannarelli M.; Marchetti M.; Magalhaes J.; Bettati S.; Mozzarelli A.; Cabassi C.S.; Campanini B.; Costantino G./titolo:Investigational Studies on a Hit Compound Cyclopropane-Carboxylic Acid Derivative Targeting O-Acetylserine Sulfhydrylase as a Colistin Adjuvant/doi:10.1021%2Facsinfecdis.0c00378/rivista:ACS Infectious Diseases/anno:2021/pagina_da:281/pagina_a:292/intervallo_pagine:281–292/volume:7
info:cnr-pdr/source/autori:Annunziato G.; Spadini C.; Franko N.; Storici P.; Demitri N.; Pieroni M.; Flisi S.; Rosati L.; Iannarelli M.; Marchetti M.; Magalhaes J.; Bettati S.; Mozzarelli A.; Cabassi C.S.; Campanini B.; Costantino G./titolo:Investigational Studies on a Hit Compound Cyclopropane-Carboxylic Acid Derivative Targeting O-Acetylserine Sulfhydrylase as a Colistin Adjuvant/doi:10.1021%2Facsinfecdis.0c00378/rivista:ACS Infectious Diseases/anno:2021/pagina_da:281/pagina_a:292/intervallo_pagine:281–292/volume:7
Antibacterial adjuvants are of great significance, since they allow the therapeutic dose of conventional antibiotics to be lowered and reduce the insurgence of antibiotic resistance. Herein, we report that an O-acetylserine sulfhydrylase (OASS) inhib
Autor:
Luigi Cari, Lucrezia Rosati, Giuseppe Leoncini, Eleonora Lusenti, Marco Gentili, Giuseppe Nocentini, Carlo Riccardi, Graziella Migliorati, Simona Ronchetti
Publikováno v:
International Journal of Molecular Sciences
Volume 24
Issue 3
Pages: 2235
Volume 24
Issue 3
Pages: 2235
Ulcerative colitis (UC) and Crohn’s Disease (CD) are chronic relapsing inflammatory diseases that are caused by genetic, environmental, and immune factors. Treatment strategies are currently based on symptomatic control by immunosuppression. The gl
Autor:
Giannamaria, Annunziato, Costanza, Spadini, Nina, Franko, Paola, Storici, Nicola, Demitri, Marco, Pieroni, Sara, Flisi, Lucrezia, Rosati, Mattia, Iannarelli, Marialaura, Marchetti, Joana, Magalhaes, Stefano, Bettati, Andrea, Mozzarelli, Clotilde Silvia, Cabassi, Barbara, Campanini, Gabriele, Costantino
Publikováno v:
ACS infectious diseases. 7(2)
Antibacterial adjuvants are of great significance, since they allow the therapeutic dose of conventional antibiotics to be lowered and reduce the insurgence of antibiotic resistance. Herein, we report that an